RetinalGenix Technologies Inc.
RetinalGenix Technologies Inc.
No insider data available
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||||||||
Assets Current | |||||||||||||||||
Assets Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | |||||
Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | 0 | |||||
Property Plant And Equipment Net | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Right Of Use Asset | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |||||
Security Deposit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |||||
Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Liabilities And Stockhold… | |||||||||||||||||
Liabilities | |||||||||||||||||
Accounts Payable And Accrued Liabilities Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Liabilities Current | |||||||||||||||||
Liabilities Current | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | - | - | 1 | - | |||||
Notes Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |||||
Interest Payable Current | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Operating Lease Liability Noncurrent | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - | - | - | - | |||||
Liabilities | 3 | 3 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 1 | 1 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital | 16 | 16 | 16 | 15 | 15 | 14 | 14 | 13 | 12 | 12 | 10 | 9 | |||||
Stockholders Equity | |||||||||||||||||
Stockholders Equity | -3 | -3 | -2 | -2 | -2 | -2 | -1 | -2 | -2 | -2 | -1 | -1 | |||||
Stockholders Equity Note Subscriptions Receivable | - | - | -0 | - | - | - | -0 | - | - | - | - | - | |||||
Retained Earnings Accumulated Deficit | -19 | -18 | -18 | -17 | -17 | -16 | -15 | -15 | -14 | -13 | -11 | -11 | |||||
Liabilities And Stockholders Equity | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Accumulated Depreciation Depletion And Amortizatio… | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Preferred Stock Shares Authorized | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | 40 | |||||
Common Stock Par Or Stated Value Per Share | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Shares Authorized | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | 80 | |||||
Common Stock Shares Issued | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | |||||
Shares Outstanding | 19 | 19 | 19 | 19 | 19 | 19 | 19 | 18 | 18 | 18 | 18 | 18 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | 0.00% | 0.00% | 0.00% | - | - | - | - | - | - | - | - | - |
| 2025 | 0.00% | 0.00% | -29.48% | 0.00% | 0.00% | -9.60% | 0.00% | 0.00% | 0.00% | 25.00% | 25.00% | 25.00% |
| 2024 | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -54.29% | 81.71% | -42.57% | 149.76% | 149.76% | 149.76% |
| 2023 | - | - | - | - | - | - | 0.00% | 0.00% | 0.32% | 0.00% | 0.00% | 0.00% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | - | - | - | - | |||||
| Quick Ratio | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 | - | - | - | - | |||||
| Working Capital | -2.64M | -2.56M | -2.31M | -2.17M | -1.98M | -1.67M | -1.46M | -1.86M | - | - | - | - | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | -1.01 | -1.00 | -1.01 | -1.00 | -1.00 | -1.01 | -1.01 | -1.05 | - | - | -1.00 | - | |||||
| Interest Coverage TTM | -287.61 | -557.27 | -605.39 | -684.78 | -703.79 | -728.01 | -1,124.22 | -1,039.48 | -1,050.46 | -969.34 | -543.50 | -578.37 | |||||
| Debt Ratio | 82.97 | 441.67 | 110.43 | 311.35 | 237.19 | 140.80 | 98.86 | 21.87 | - | - | - | - | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | - | 0.00 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | -0.11 | -0.13 | -0.13 | -0.14 | -0.15 | -0.15 | -0.24 | -0.22 | -0.23 | -0.21 | -0.12 | -0.13 | |||||
| Free Cash Flow Per Share TTM | -0.03 | -0.03 | -0.03 | -0.02 | -0.03 | -0.04 | -0.04 | -0.05 | -0.03 | -0.03 | -0.03 | -0.01 | |||||
| Dividend Per Share TTM | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||||
Growth Metrics | |||||||||||||||||
| Net Income Growth (1Y) | -23.95% | -11.96% | -43.79% | -33.11% | -31.94% | -25.87% | 106.65% | 79.63% | -0.11% | -7.98% | -46.58% | -54.30% | |||||
| EPS Growth (1Y) | -25.90% | -13.05% | -45.68% | -35.31% | -33.66% | -29.27% | 99.87% | 72.69% | -3.42% | -10.07% | -52.02% | -56.18% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | -36.00 | -24.68 | -24.46 | -24.61 | -33.48 | -13.48 | -6.64 | -15.74 | -15.49 | -16.60 | -25.64 | -34.87 | |||||
| P/B TTM | -28.49 | -23.46 | -25.80 | -30.27 | -46.44 | -22.32 | -19.63 | -33.92 | -34.52 | -40.72 | -38.14 | -71.65 | |||||
| Market Cap | 75.23M | 60.02M | 59.40M | 65.77M | 92.00M | 37.23M | 28.71M | 62.90M | 62.52M | 61.85M | 53.62M | 77.57M | |||||
| Enterprise Value | 75.25M | 60.06M | 59.43M | 65.82M | 92.05M | 37.27M | 28.75M | 62.87M | 62.48M | 61.85M | 53.67M | 77.62M | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | -555.95K | -480.34K | -558.35K | -429.30K | -572.39K | -765.34K | -741.94K | -845.57K | -558.89K | -537.91K | -451.66K | -194.86K | |||||
| Net Debt | 21.77K | 48.82K | 34.23K | 48.91K | 48.16K | 45.29K | 42.94K | -30.09K | -37.91K | -1.39K | 49.00K | 48.96K | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
RetinalGenix Technologies Inc. (RTGN) — SEC Financial Statements & Analysis
RetinalGenix Technologies Inc. (RTGN) is a surgical & medical instruments & apparatus company, incorporated in DE. RetinalGenix Technologies Inc. trades on OTC as: RTGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), RetinalGenix Technologies Inc. reported a Debt-to-Equity ratio of -1.01x, a Price-to-Book (P/B) ratio of -28.49x (TTM), at a market cap of $75.23M. Figures below are sourced from SEC EDGAR, as-filed.
- Debt To Equity
- -1.01x
- P/B TTM
- -28.49x
- Market Cap
- $75.23M
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is RetinalGenix Technologies Inc. in?
RetinalGenix Technologies Inc. (RTGN) operates in the Surgical & Medical Instruments & Apparatus industry.
What is RTGN's market cap?
RetinalGenix Technologies Inc. (RTGN) has a market capitalization of $75.23M as of 2026-06-30.
What exchange does RTGN trade on?
RetinalGenix Technologies Inc. (RTGN) trades on the OTC.
Where is RetinalGenix Technologies Inc. incorporated?
RetinalGenix Technologies Inc. is incorporated in DE.